Fig. 1From: Platelets, diabetes and myocardial ischemia/reperfusion injuryAspirin’s target in platelets: aspirin inhibits cyclo-Oxygenase-1 (COX-1), limiting thromboxane A2 (TXA2) formation. The thickness of line represents the power of aspirin in inhibiting COX, which is about 200-fold higher for COX-1 than COX-2, whose role in platelet function is not clearBack to article page